| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vulvar Lichen Sclerosus | 5 | 2022 | 10 | 2.720 |
Why?
|
| Vagina | 19 | 2023 | 849 | 2.660 |
Why?
|
| Developmental Disabilities | 10 | 2024 | 1518 | 2.370 |
Why?
|
| Mullerian Ducts | 11 | 2023 | 203 | 2.160 |
Why?
|
| Menorrhagia | 9 | 2022 | 59 | 2.130 |
Why?
|
| Gynecologic Surgical Procedures | 12 | 2022 | 287 | 1.810 |
Why?
|
| Uterus | 9 | 2023 | 661 | 1.680 |
Why?
|
| Menstruation Disturbances | 7 | 2015 | 143 | 1.660 |
Why?
|
| Ovarian Diseases | 3 | 2023 | 135 | 1.640 |
Why?
|
| Urogenital Abnormalities | 4 | 2022 | 255 | 1.610 |
Why?
|
| Menstruation | 8 | 2023 | 310 | 1.510 |
Why?
|
| Lichen Sclerosus et Atrophicus | 2 | 2022 | 26 | 1.470 |
Why?
|
| Uterine Hemorrhage | 4 | 2023 | 236 | 1.400 |
Why?
|
| Vulvar Diseases | 4 | 2017 | 64 | 1.400 |
Why?
|
| Congenital Abnormalities | 10 | 2023 | 703 | 1.370 |
Why?
|
| 46, XX Disorders of Sex Development | 6 | 2023 | 34 | 1.250 |
Why?
|
| Gynecology | 7 | 2021 | 534 | 1.200 |
Why?
|
| Spinal Dysraphism | 5 | 2020 | 179 | 1.160 |
Why?
|
| Genitalia, Female | 3 | 2017 | 146 | 1.160 |
Why?
|
| Torsion Abnormality | 3 | 2023 | 92 | 1.130 |
Why?
|
| Hymen | 4 | 2022 | 18 | 1.120 |
Why?
|
| Menarche | 5 | 2023 | 538 | 1.100 |
Why?
|
| Disabled Persons | 8 | 2023 | 1209 | 1.100 |
Why?
|
| Sex Education | 4 | 2020 | 94 | 1.040 |
Why?
|
| Genital Diseases, Female | 2 | 2019 | 192 | 1.010 |
Why?
|
| Cysts | 4 | 2023 | 685 | 0.940 |
Why?
|
| Endometriosis | 5 | 2014 | 873 | 0.880 |
Why?
|
| Progestins | 2 | 2023 | 302 | 0.850 |
Why?
|
| Adolescent | 70 | 2024 | 89046 | 0.790 |
Why?
|
| Vulvovaginitis | 1 | 2020 | 14 | 0.730 |
Why?
|
| Menstrual Cycle | 5 | 2016 | 546 | 0.680 |
Why?
|
| Ovarian Cysts | 1 | 2020 | 108 | 0.670 |
Why?
|
| Angiokeratoma | 1 | 2019 | 5 | 0.660 |
Why?
|
| Reproductive Health Services | 3 | 2020 | 90 | 0.640 |
Why?
|
| Ovarian Neoplasms | 3 | 2023 | 4903 | 0.630 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2019 | 383 | 0.620 |
Why?
|
| Endometrial Hyperplasia | 1 | 2019 | 102 | 0.610 |
Why?
|
| Ovariectomy | 1 | 2020 | 612 | 0.600 |
Why?
|
| Dysmenorrhea | 3 | 2020 | 107 | 0.570 |
Why?
|
| Endometrial Neoplasms | 2 | 2019 | 1381 | 0.570 |
Why?
|
| Female | 104 | 2024 | 396660 | 0.570 |
Why?
|
| Breast Cyst | 1 | 2017 | 8 | 0.560 |
Why?
|
| Vulvar Neoplasms | 3 | 2011 | 266 | 0.560 |
Why?
|
| Dyspareunia | 2 | 2014 | 48 | 0.560 |
Why?
|
| Laparoscopy | 7 | 2022 | 2037 | 0.560 |
Why?
|
| Personal Satisfaction | 1 | 2021 | 643 | 0.530 |
Why?
|
| Adolescent Development | 2 | 2017 | 276 | 0.530 |
Why?
|
| Mosaicism | 3 | 2015 | 480 | 0.510 |
Why?
|
| Abnormalities, Multiple | 3 | 2013 | 1424 | 0.510 |
Why?
|
| Hypothyroidism | 1 | 2020 | 667 | 0.500 |
Why?
|
| Puberty | 3 | 2014 | 501 | 0.490 |
Why?
|
| Breast | 4 | 2017 | 1972 | 0.480 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2014 | 10 | 0.480 |
Why?
|
| Gonadoblastoma | 1 | 2014 | 14 | 0.480 |
Why?
|
| Confidentiality | 2 | 2020 | 607 | 0.470 |
Why?
|
| Sclerotherapy | 1 | 2016 | 183 | 0.470 |
Why?
|
| Sexual Behavior | 7 | 2022 | 2196 | 0.470 |
Why?
|
| Tissue Adhesions | 2 | 2015 | 222 | 0.460 |
Why?
|
| Lymphatic Abnormalities | 1 | 2016 | 134 | 0.460 |
Why?
|
| Contraceptives, Oral, Hormonal | 4 | 2020 | 190 | 0.450 |
Why?
|
| Parental Consent | 1 | 2014 | 63 | 0.450 |
Why?
|
| Child | 32 | 2023 | 80771 | 0.450 |
Why?
|
| Mouth Mucosa | 2 | 2014 | 435 | 0.440 |
Why?
|
| Sterilization, Reproductive | 2 | 2011 | 24 | 0.440 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 1104 | 0.430 |
Why?
|
| CA-125 Antigen | 2 | 2021 | 281 | 0.430 |
Why?
|
| Third-Party Consent | 2 | 2011 | 66 | 0.430 |
Why?
|
| Cervix Uteri | 3 | 2017 | 575 | 0.420 |
Why?
|
| Gynecological Examination | 3 | 2020 | 32 | 0.410 |
Why?
|
| Humans | 105 | 2024 | 767040 | 0.390 |
Why?
|
| Retrospective Studies | 27 | 2023 | 81659 | 0.380 |
Why?
|
| Kidney Diseases | 1 | 2022 | 2099 | 0.370 |
Why?
|
| Minors | 1 | 2011 | 59 | 0.360 |
Why?
|
| Uterine Diseases | 2 | 2013 | 108 | 0.350 |
Why?
|
| Educational Measurement | 1 | 2017 | 1259 | 0.350 |
Why?
|
| Vascular Malformations | 1 | 2016 | 469 | 0.350 |
Why?
|
| Premenstrual Syndrome | 2 | 2015 | 111 | 0.340 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2023 | 4054 | 0.340 |
Why?
|
| Attitude of Health Personnel | 4 | 2019 | 3928 | 0.340 |
Why?
|
| Self Concept | 2 | 2006 | 1041 | 0.320 |
Why?
|
| Caregivers | 1 | 2021 | 2302 | 0.310 |
Why?
|
| Michigan | 4 | 2020 | 329 | 0.310 |
Why?
|
| Pelvic Pain | 4 | 2017 | 300 | 0.310 |
Why?
|
| Glucocorticoids | 2 | 2019 | 2163 | 0.310 |
Why?
|
| Vaginal Smears | 2 | 2009 | 505 | 0.300 |
Why?
|
| Testicular Neoplasms | 1 | 2014 | 806 | 0.300 |
Why?
|
| Amenorrhea | 2 | 2014 | 484 | 0.290 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2022 | 364 | 0.290 |
Why?
|
| Ulcer | 1 | 2008 | 203 | 0.280 |
Why?
|
| Menopause | 5 | 2024 | 1655 | 0.280 |
Why?
|
| Women's Health | 4 | 2020 | 2082 | 0.280 |
Why?
|
| Emergency Service, Hospital | 4 | 2023 | 7871 | 0.280 |
Why?
|
| Cytological Techniques | 1 | 2009 | 217 | 0.280 |
Why?
|
| Dermatitis | 1 | 2008 | 203 | 0.270 |
Why?
|
| Cerebral Palsy | 2 | 2009 | 480 | 0.270 |
Why?
|
| Young Adult | 27 | 2022 | 59980 | 0.270 |
Why?
|
| Child, Preschool | 13 | 2023 | 42606 | 0.270 |
Why?
|
| Neurofibromatosis 1 | 1 | 2011 | 561 | 0.260 |
Why?
|
| Estrogens | 3 | 2023 | 1536 | 0.250 |
Why?
|
| Myometrium | 1 | 2006 | 174 | 0.250 |
Why?
|
| Administration, Topical | 3 | 2019 | 703 | 0.250 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2006 | 155 | 0.240 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2005 | 39 | 0.240 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2009 | 391 | 0.240 |
Why?
|
| Condylomata Acuminata | 1 | 2005 | 79 | 0.240 |
Why?
|
| Contraceptives, Oral, Combined | 3 | 2020 | 118 | 0.240 |
Why?
|
| Child Abuse, Sexual | 2 | 2020 | 398 | 0.240 |
Why?
|
| Health Promotion | 1 | 2017 | 2210 | 0.240 |
Why?
|
| Contraception | 3 | 2022 | 362 | 0.230 |
Why?
|
| Pain | 4 | 2022 | 5101 | 0.230 |
Why?
|
| Hematocolpos | 1 | 2003 | 5 | 0.220 |
Why?
|
| Hemorrhagic Disorders | 2 | 2021 | 34 | 0.220 |
Why?
|
| Hysterectomy | 3 | 2021 | 863 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2021 | 2038 | 0.210 |
Why?
|
| Vulva | 2 | 2022 | 84 | 0.210 |
Why?
|
| Pregnancy in Adolescence | 1 | 2024 | 166 | 0.210 |
Why?
|
| Adolescent Medicine | 1 | 2003 | 73 | 0.200 |
Why?
|
| Turner Syndrome | 1 | 2003 | 130 | 0.200 |
Why?
|
| Hydrocolpos | 1 | 2022 | 2 | 0.200 |
Why?
|
| Vaginal Discharge | 1 | 2002 | 25 | 0.200 |
Why?
|
| Hygiene | 2 | 2016 | 95 | 0.200 |
Why?
|
| Depression | 3 | 2021 | 8234 | 0.200 |
Why?
|
| Vaginal Diseases | 1 | 2003 | 103 | 0.200 |
Why?
|
| Muscle Spasticity | 1 | 2003 | 159 | 0.200 |
Why?
|
| Pelvic Floor | 1 | 2003 | 138 | 0.190 |
Why?
|
| Adnexa Uteri | 1 | 2021 | 40 | 0.190 |
Why?
|
| Adult | 34 | 2024 | 223317 | 0.190 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 12986 | 0.190 |
Why?
|
| Counseling | 3 | 2021 | 1553 | 0.180 |
Why?
|
| Down Syndrome | 1 | 2009 | 916 | 0.180 |
Why?
|
| Parents | 4 | 2020 | 3594 | 0.180 |
Why?
|
| Levonorgestrel | 1 | 2021 | 80 | 0.180 |
Why?
|
| Medical History Taking | 2 | 2014 | 779 | 0.180 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 4210 | 0.180 |
Why?
|
| Anxiety | 3 | 2021 | 4670 | 0.170 |
Why?
|
| Poliomyelitis | 3 | 2006 | 91 | 0.170 |
Why?
|
| Lacerations | 1 | 2022 | 150 | 0.170 |
Why?
|
| Physicians | 2 | 2017 | 4593 | 0.170 |
Why?
|
| Pregnancy | 9 | 2024 | 30238 | 0.170 |
Why?
|
| Contraceptive Agents, Female | 2 | 2014 | 123 | 0.170 |
Why?
|
| Syndrome | 2 | 2020 | 3271 | 0.170 |
Why?
|
| Autistic Disorder | 1 | 2009 | 1239 | 0.170 |
Why?
|
| Hospitalization | 1 | 2019 | 10815 | 0.170 |
Why?
|
| Ointments | 1 | 2019 | 58 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5859 | 0.160 |
Why?
|
| Clobetasol | 1 | 2019 | 33 | 0.160 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2021 | 116 | 0.160 |
Why?
|
| Triamcinolone | 1 | 2019 | 68 | 0.160 |
Why?
|
| Job Satisfaction | 2 | 2015 | 548 | 0.160 |
Why?
|
| Hemochromatosis | 1 | 2020 | 175 | 0.160 |
Why?
|
| Hormone Replacement Therapy | 2 | 2020 | 756 | 0.160 |
Why?
|
| von Willebrand Diseases | 1 | 2020 | 135 | 0.160 |
Why?
|
| Papillomaviridae | 1 | 2005 | 1139 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2014 | 4859 | 0.150 |
Why?
|
| Case-Control Studies | 3 | 2023 | 22254 | 0.150 |
Why?
|
| Urologic Diseases | 1 | 2021 | 246 | 0.150 |
Why?
|
| Mammaplasty | 2 | 2009 | 1268 | 0.150 |
Why?
|
| Fecal Incontinence | 1 | 2021 | 246 | 0.150 |
Why?
|
| Foreign Bodies | 1 | 2002 | 403 | 0.150 |
Why?
|
| Dilatation | 2 | 2022 | 311 | 0.150 |
Why?
|
| Gonadal Dysgenesis | 1 | 2017 | 28 | 0.140 |
Why?
|
| Psychosexual Development | 1 | 2017 | 19 | 0.140 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2017 | 56 | 0.140 |
Why?
|
| Sex Differentiation | 1 | 2017 | 73 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2017 | 5947 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2016 | 9410 | 0.140 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 289 | 0.140 |
Why?
|
| Obesity | 1 | 2019 | 13085 | 0.140 |
Why?
|
| Blood Coagulation Disorders | 1 | 2019 | 350 | 0.130 |
Why?
|
| Abdominal Pain | 2 | 2018 | 1069 | 0.130 |
Why?
|
| Professional-Family Relations | 1 | 2020 | 501 | 0.130 |
Why?
|
| Obstetric Labor Complications | 1 | 2018 | 240 | 0.130 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 385 | 0.130 |
Why?
|
| Nausea | 1 | 2018 | 682 | 0.120 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2015 | 116 | 0.120 |
Why?
|
| Anemia | 2 | 2022 | 1514 | 0.120 |
Why?
|
| Vomiting | 1 | 2018 | 655 | 0.120 |
Why?
|
| Virilism | 1 | 2014 | 28 | 0.120 |
Why?
|
| Mass Screening | 2 | 2021 | 5456 | 0.120 |
Why?
|
| Surgically-Created Structures | 1 | 2014 | 9 | 0.120 |
Why?
|
| Life Style | 1 | 2006 | 3931 | 0.120 |
Why?
|
| Faculty, Medical | 2 | 2015 | 1227 | 0.120 |
Why?
|
| Disorders of Sex Development | 1 | 2015 | 129 | 0.120 |
Why?
|
| Self Disclosure | 1 | 2015 | 248 | 0.120 |
Why?
|
| Chromosomes, Human, Y | 1 | 2015 | 163 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2020 | 36582 | 0.110 |
Why?
|
| Asthma | 1 | 2013 | 6268 | 0.110 |
Why?
|
| Steroids | 1 | 2019 | 937 | 0.110 |
Why?
|
| Doxycycline | 1 | 2016 | 348 | 0.110 |
Why?
|
| Angelman Syndrome | 1 | 2015 | 139 | 0.110 |
Why?
|
| Endosonography | 1 | 2017 | 626 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2023 | 6000 | 0.110 |
Why?
|
| Self Efficacy | 2 | 2015 | 643 | 0.110 |
Why?
|
| Vulvodynia | 1 | 2013 | 7 | 0.110 |
Why?
|
| Chromosomes, Human, X | 1 | 2015 | 319 | 0.110 |
Why?
|
| Leiomyoma | 1 | 2018 | 644 | 0.110 |
Why?
|
| Pelvis | 1 | 2017 | 736 | 0.110 |
Why?
|
| Career Mobility | 1 | 2015 | 262 | 0.110 |
Why?
|
| Pregnancy, Ectopic | 1 | 2014 | 144 | 0.110 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2018 | 399 | 0.110 |
Why?
|
| Kidney | 2 | 2022 | 7063 | 0.100 |
Why?
|
| Thrombosis | 2 | 2022 | 2954 | 0.100 |
Why?
|
| Sexual Maturation | 1 | 2014 | 258 | 0.100 |
Why?
|
| Cystitis, Interstitial | 1 | 2013 | 68 | 0.100 |
Why?
|
| Quality of Life | 5 | 2023 | 13485 | 0.100 |
Why?
|
| Pregnancy Complications | 2 | 2018 | 2971 | 0.100 |
Why?
|
| Physical Examination | 2 | 2009 | 1265 | 0.100 |
Why?
|
| Mental Health | 1 | 2006 | 3272 | 0.100 |
Why?
|
| Genital Neoplasms, Female | 1 | 2017 | 535 | 0.100 |
Why?
|
| Cross-Sectional Studies | 10 | 2024 | 26325 | 0.090 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 1856 | 0.090 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2013 | 217 | 0.090 |
Why?
|
| Qualitative Research | 5 | 2022 | 3139 | 0.090 |
Why?
|
| Medical Staff | 1 | 2010 | 40 | 0.090 |
Why?
|
| Referral and Consultation | 2 | 2021 | 3618 | 0.090 |
Why?
|
| Patient Preference | 1 | 2017 | 947 | 0.090 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2013 | 226 | 0.080 |
Why?
|
| Peer Group | 1 | 2015 | 702 | 0.080 |
Why?
|
| Delayed Diagnosis | 1 | 2013 | 454 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2022 | 41718 | 0.080 |
Why?
|
| Paraplegia | 1 | 2010 | 161 | 0.080 |
Why?
|
| Physicians, Women | 1 | 2015 | 516 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2018 | 1424 | 0.080 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2008 | 33 | 0.080 |
Why?
|
| Norethindrone | 2 | 2006 | 56 | 0.080 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2009 | 41 | 0.080 |
Why?
|
| Sexuality | 2 | 2022 | 179 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1883 | 0.080 |
Why?
|
| Tissue Expansion Devices | 1 | 2009 | 160 | 0.080 |
Why?
|
| Quadriplegia | 1 | 2010 | 227 | 0.080 |
Why?
|
| Ferritins | 2 | 2022 | 601 | 0.080 |
Why?
|
| Infertility, Female | 1 | 2014 | 763 | 0.080 |
Why?
|
| Family | 1 | 2019 | 3210 | 0.080 |
Why?
|
| Fibromyalgia | 1 | 2013 | 407 | 0.080 |
Why?
|
| Depressive Disorder | 1 | 2021 | 3721 | 0.070 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 1432 | 0.070 |
Why?
|
| Body Mass Index | 4 | 2019 | 13048 | 0.070 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2013 | 454 | 0.070 |
Why?
|
| Medicine | 1 | 2015 | 944 | 0.070 |
Why?
|
| Iliac Artery | 1 | 2009 | 344 | 0.070 |
Why?
|
| Social Support | 1 | 2017 | 2192 | 0.070 |
Why?
|
| Hospitals, University | 1 | 2009 | 570 | 0.070 |
Why?
|
| Prevalence | 2 | 2014 | 15851 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2009 | 2270 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 2009 | 381 | 0.070 |
Why?
|
| Hormone Antagonists | 1 | 2006 | 108 | 0.070 |
Why?
|
| Coitus | 1 | 2006 | 132 | 0.060 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2005 | 16 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3266 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2022 | 26396 | 0.060 |
Why?
|
| Breast Implants | 1 | 2009 | 414 | 0.060 |
Why?
|
| Hormones | 2 | 2022 | 865 | 0.060 |
Why?
|
| Male | 13 | 2019 | 364203 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2023 | 65295 | 0.060 |
Why?
|
| Biopsy | 2 | 2008 | 6777 | 0.060 |
Why?
|
| Necrosis | 1 | 2009 | 1614 | 0.060 |
Why?
|
| Headache | 1 | 2013 | 1261 | 0.060 |
Why?
|
| Urethra | 2 | 2022 | 406 | 0.060 |
Why?
|
| Infant | 5 | 2018 | 36485 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2013 | 989 | 0.060 |
Why?
|
| Recurrence | 2 | 2015 | 8504 | 0.060 |
Why?
|
| Metaphase | 1 | 2003 | 143 | 0.060 |
Why?
|
| Cognition Disorders | 2 | 2015 | 3968 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2010 | 1480 | 0.050 |
Why?
|
| Hirsutism | 1 | 2002 | 68 | 0.050 |
Why?
|
| Teaching | 1 | 2010 | 1172 | 0.050 |
Why?
|
| Gonadotropins | 1 | 2003 | 241 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 40154 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2010 | 927 | 0.050 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2009 | 807 | 0.050 |
Why?
|
| Hysteroscopy | 1 | 2002 | 62 | 0.050 |
Why?
|
| Rectum | 2 | 2022 | 898 | 0.050 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2005 | 360 | 0.050 |
Why?
|
| Cloaca | 1 | 2022 | 52 | 0.050 |
Why?
|
| United States | 6 | 2021 | 72971 | 0.050 |
Why?
|
| Middle Aged | 14 | 2024 | 223233 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2002 | 297 | 0.050 |
Why?
|
| Thrombasthenia | 1 | 2020 | 21 | 0.040 |
Why?
|
| Orgasm | 1 | 2020 | 62 | 0.040 |
Why?
|
| Medical Errors | 1 | 2009 | 1260 | 0.040 |
Why?
|
| Bone Development | 1 | 2003 | 473 | 0.040 |
Why?
|
| Urination Disorders | 1 | 2021 | 236 | 0.040 |
Why?
|
| Hair | 1 | 2003 | 508 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2005 | 963 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2003 | 490 | 0.040 |
Why?
|
| Pregnancy, Unplanned | 1 | 2019 | 85 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2013 | 9362 | 0.040 |
Why?
|
| Abscess | 1 | 2022 | 606 | 0.040 |
Why?
|
| Comorbidity | 1 | 2013 | 10582 | 0.040 |
Why?
|
| Fear | 2 | 2017 | 1496 | 0.040 |
Why?
|
| Psychometrics | 2 | 2023 | 3060 | 0.040 |
Why?
|
| Women | 1 | 2019 | 225 | 0.040 |
Why?
|
| Body Height | 1 | 2003 | 1565 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2003 | 1776 | 0.030 |
Why?
|
| Hematoma | 1 | 2022 | 766 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2022 | 805 | 0.030 |
Why?
|
| Risk Factors | 3 | 2022 | 74886 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 707 | 0.030 |
Why?
|
| Internal-External Control | 1 | 2017 | 348 | 0.030 |
Why?
|
| Smoking | 1 | 2013 | 9081 | 0.030 |
Why?
|
| Constipation | 1 | 2021 | 570 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2020 | 54886 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 20169 | 0.030 |
Why?
|
| Postmenopause | 1 | 2004 | 2518 | 0.030 |
Why?
|
| Leg | 1 | 2020 | 1087 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1253 | 0.030 |
Why?
|
| Metformin | 1 | 2002 | 908 | 0.030 |
Why?
|
| Sex Offenses | 1 | 2019 | 355 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 804 | 0.030 |
Why?
|
| Contraceptive Agents | 1 | 2015 | 147 | 0.030 |
Why?
|
| Intrauterine Devices | 1 | 2015 | 115 | 0.030 |
Why?
|
| Age Distribution | 1 | 2020 | 2870 | 0.030 |
Why?
|
| Twins | 1 | 2015 | 341 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2658 | 0.030 |
Why?
|
| Focus Groups | 1 | 2020 | 1460 | 0.030 |
Why?
|
| Survivors | 1 | 2004 | 2381 | 0.030 |
Why?
|
| Body Composition | 1 | 2003 | 2454 | 0.030 |
Why?
|
| Iron | 1 | 2022 | 1811 | 0.030 |
Why?
|
| Prognosis | 1 | 2013 | 29963 | 0.030 |
Why?
|
| Health Education | 1 | 2019 | 1058 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 1000 | 0.020 |
Why?
|
| Trust | 1 | 2015 | 532 | 0.020 |
Why?
|
| Endometrium | 1 | 2013 | 406 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 11217 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2428 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 3108 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4539 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2020 | 2780 | 0.020 |
Why?
|
| Tissue Transplantation | 1 | 2009 | 128 | 0.020 |
Why?
|
| Mothers | 1 | 2019 | 2209 | 0.020 |
Why?
|
| Melanoma | 1 | 2006 | 5702 | 0.020 |
Why?
|
| Anal Canal | 1 | 2009 | 375 | 0.020 |
Why?
|
| Medicaid | 1 | 2020 | 2836 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3236 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2022 | 4854 | 0.020 |
Why?
|
| Analgesics | 1 | 2013 | 1071 | 0.020 |
Why?
|
| Logistic Models | 2 | 2015 | 13284 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2017 | 2516 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 8068 | 0.020 |
Why?
|
| Mentors | 1 | 2010 | 672 | 0.020 |
Why?
|
| Phenytoin | 1 | 2005 | 189 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2018 | 8732 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15925 | 0.010 |
Why?
|
| Aged | 4 | 2009 | 171319 | 0.010 |
Why?
|
| Hypertension | 1 | 2002 | 8615 | 0.010 |
Why?
|
| Robotics | 1 | 2009 | 807 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 1002 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10622 | 0.010 |
Why?
|
| Communication | 1 | 2015 | 3904 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 21526 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1419 | 0.010 |
Why?
|
| Linear Models | 1 | 2010 | 5875 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 2783 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2006 | 1209 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2004 | 1816 | 0.010 |
Why?
|
| Social Class | 1 | 2006 | 2007 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 2429 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 3488 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2005 | 1921 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2004 | 2392 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2005 | 2655 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18401 | 0.010 |
Why?
|
| Health Behavior | 1 | 2004 | 2650 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 30211 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14672 | 0.010 |
Why?
|
| Health Status | 1 | 2004 | 4091 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 7848 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 168965 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 59548 | 0.000 |
Why?
|